The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context

IntroductionGlioblastoma multiforme (GBM) pathobiology is characterized by its significant induction of immunosuppression within the tumor microenvironment, predominantly mediated by immunosuppressive tumor-associated myeloid cells (TAMCs). Myeloid cells play a pivotal role in shaping the GBM microe...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tzu-Yi Chia, Leah K. Billingham, Lauren Boland, Joshua L. Katz, Victor A. Arrieta, Jack Shireman, Aurora-Lopez Rosas, Susan L. DeLay, Kaylee Zillinger, Yuheng Geng, Jeandre Kruger, Caylee Silvers, Hanxiang Wang, Gustavo Ignacio Vazquez Cervantes, David Hou, Si Wang, Hanxiao Wan, Adam Sonabend, Peng Zhang, Catalina Lee-Chang, Jason Miska
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-01-01
Colecção:	Frontiers in Immunology
Assuntos:	glioblastoma CXCL16 CXCR6 immunotherapy myeloid cells
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1331287/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!